Search clinical trials for: Tiotropium Bromide
Total 906 results
-
Lundquist Institute for Biomedical Innovation at...Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedEfficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsChronic Obstructive Pulmonary Disease (COPD)Germany
-
Daewoong Pharmaceutical Co. LTD.Completed
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Australia, United States, Germany, Chile, Korea, Republic of, Mexico, Canada, South Africa, Romania
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Germany
-
University of MilanFondazione Salvatore MaugeriCompleted
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Shanghai Zhongshan HospitalUnknownChronic Obstructive Pulmonary DiseaseChina
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Novartis PharmaceuticalsCompleted
-
Glenmark Specialty S.A.CompletedMild to Moderate Chronic Obstructive Pulmonary Disease (COPD)United States
-
Phargentis SACompleted
-
University of DundeeCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Ukraine, Germany, Peru, Poland, France, Romania, Italy, Mexico
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Botanix PharmaceuticalsCompletedPrimary Axillary HyperhidrosisUnited States
-
AstraZenecaMenarini GroupCompletedPulmonary Disease, Chronic ObstructiveItaly, Spain, United Kingdom, Germany, Hungary
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Romania, Poland, Czechia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompletedAsthmaAustria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Russian Federation, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Denmark, Finland, Germany, Netherlands
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaCompleted
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
Cothera Bioscience, IncRecruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphatic Diseases | Burkitt Lymphoma | High-grade B-cell Lymphoma | C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma | C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma | Lymphoma, High-Grade | C-Myc Gene RearrangementKorea, Republic of, China
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
University of Rome Tor VergataUnknown
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Lithuania, Slovakia, United Kingdom
-
NPO PetrovaxCompletedInfections, CoronavirusBelarus, Russian Federation
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina, Korea, Republic of
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Mel Shiuann-Sheng LeeNovartisCompletedFunctional Outcomes | Prevention of BMD Loss After THR | Serum Markers of Bone TurnoverTaiwan
-
Botanix PharmaceuticalsCompletedPrimary Axillary HyperhidrosisUnited States
-
NPO PetrovaxActive, not recruitingInfections, CoronavirusRussian Federation, Slovakia
-
Boehringer IngelheimCompleted
-
Maastricht University Medical CenterAstraZeneca; Center for Integrated Rehabilitation and Organ Failure HornUnknownChronic Obstructive Airway DiseaseNetherlands
-
Children's Hospital of PhiladelphiaAuto Dealers Caring for Kids FoundationCompleted